Grade III Meningioma, Adult
1 clinical trials · Condition
◉ Watch Grade III Meningioma, Adult
| Record | Firm | Date |
|---|---|---|
| Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma (NCT04659811) | Nancy Ann Oberheim Bush, MD | 2021-03-25 |
Track Grade III Meningioma, Adult automatically
Every clearance here is in the API, with alerts when new ones post.